Barclays PLC
NYSE:BCSBanks - Diversified
+$0.12 today
- Market cap
- $72.23B
- Beta
- 0.90
- P/E (TTM)
- 9.5
- EPS (TTM)
- $0.53
- Dividend yield
- 1.72%
Volume 4.84M
Average 6.73M
BCS Operating Expenses
Total costs of running the business that are not directly tied to producing goods or services sold.
Barclays PLCNYSE: BCS
Operating Expenses · Q3 FY2026 · quarter ended Sep 2026
Operating expenses growth accelerates
Q3 FY2026 operating expenses of £4.56B rose 14.0% year over year, ahead of the +8.4% change in trailing-twelve-month operating expenses. Sequentially, it rose 0.2% from the prior quarter. Over 3 fiscal years it compounded at +6.6% a year.
Context
- Operating expenses amounted to 39.4% of revenue in FY2025, up 2.8 pp from a year earlier.
- Operating expenses increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +14.0% holds above the trailing-twelve-month pace of +8.4%.
Sources:Income StatementText generated from reported figures; not investment advice.
Operating Expenses history
GBP · from the income statement
- Latest · FY2025
- 20B GBP
- Year-over-year change
- -3.9%
- 4-year CAGR
- +9.8%
| Period | Period end | Operating Expenses | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 20B | -3.9% |
| FY2024 | 2024-12-31 | 20.81B | +7.3% |
| FY2023 | 2023-12-31 | 19.4B | +17.5% |
| FY2022 | 2022-12-31 | 16.52B | +20.0% |
| FY2021 | 2021-12-31 | 13.76B | — |
Operating Expenses vs competitors
How BCS compares with its peers on the latest reported figures
- Peers report in different currencies, so operating expenses is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +8.4% is the 5th highest of 9, against a peer median of +7.9%.
- Operating expenses amounts to 58.6% of revenue for BCS, versus a peer median of 34.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $105.44B USD | +11.7% | +8.1% | 34.9% | |
| LTM Sep 2026 | $74.07B USD | +7.2% | +4.3% | 38.0% | |
| LTM Sep 2026 | $56.15B USD | +2.9% | +3.0% | 36.4% | |
| LTM Jul 2026 | CA$40.82B CAD | +29.7% | +12.1% | 36.3% | |
| LTM Jul 2026 | CA$40.3B CAD | +11.4% | +9.0% | 28.2% | |
| LTM Jun 2026 | $40.17B USD | -5.5% | +3.9% | 29.9% | |
| LTM Jun 2026 | €28.37B EUR | -3.4% | +1.4% | 31.4% | |
| LTM Sep 2026 | £18.03B GBP | +8.4% | +6.6% | 58.6% | |
| LTM Jun 2026 | €16.54B EUR | +8.5% | +0.5% | 33.9% | |
| Peer median (excluding BCS) | — | +7.9% | +4.1% | 34.4% | |
Competitors are the stored peer set for BCS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 25.12B | 33.3B | 49.77B | 57.02B | 50.83B |
| Cost of Revenue | 3.17B | 9.75B | 23.91B | 27.96B | 21.69B |
| Gross Profit | 21.95B | 23.55B | 25.86B | 29.05B | 29.14B |
| Gross Margin | 87.4% | 70.7% | 52.0% | 51.0% | 57.3% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 1.97B | 10.95B | 11.77B | 11.94B | 2.73B |
| Operating Expenses | 13.76B | 16.52B | 19.4B | 20.81B | 20B |
| Depreciation & Amortization | 1.67B | 1.72B | 1.78B | 1.7B | 1.76B |
| EBITDA | 9.87B | 8.76B | 8.24B | 9.94B | 10.9B |
| EBITDA Margin | 39.3% | 26.3% | 16.6% | 17.4% | 21.4% |
| Operating Income | 8.19B | 7.04B | 6.45B | 8.28B | 9.14B |
| Operating Margin | 32.6% | 21.1% | 13.0% | 14.5% | 18.0% |
| Interest Income | 11.24B | 19.21B | 34.5B | 39.14B | 36.19B |
| Interest Expense | 3.17B | 8.56B | 22B | 25.93B | 21.69B |
| Other Income / Expenses | 0 | (6.03M) | 8.85M | (37.78M) | 0 |
| Income Before Tax | 8.19B | 7.04B | 6.46B | 8.24B | 9.14B |
| Pre-Tax Margin | 32.6% | 21.1% | 13.0% | 14.5% | 18.0% |
| Income Tax Expense | 1.14B | 1.04B | 1.21B | 1.79B | 1.93B |
| Net Income | 7.01B | 5.95B | 5.17B | 6.44B | 7.17B |
| Net Margin | 27.9% | 17.9% | 10.4% | 11.3% | 14.1% |
| EPS (Basic) | 1.48 | 1.24 | 1.12 | 1.44 | 1.80 |
| EPS (Diluted) | 1.44 | 1.20 | 1.08 | 1.40 | 1.80 |
| Weighted Avg Shares | 4.25B | 4.08B | 3.86B | 3.69B | 3.45B |
| Weighted Avg Shares (Diluted) | 4.36B | 4.22B | 3.97B | 3.82B | 3.45B |
Barclays PLC
NYSE:BCS
Intrinsic Alpha fair value
Locked
Current Price
$21.60
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.